Hollywood ‘Spirituality Guru’ (Oprah's) Marianne

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
256
Hollywood ‘Spirituality Guru’ (Oprah's)
Marianne Williamson to Challenge Trump in 2020
< >

MarianneWilliamson1-640x480.jpg

Marianne Williamson, Politico reports, who is Oprah Winfrey’s purported “spiritual guru” is preparing White House run against President Donald Trump in 2020.

“Marianne Williamson — pal of Oprah Winfrey, spirituality guru and fixture of Hollywood’s New Age community, is preparing for a 2020 run against President Donald Trump,” Politico reported on Friday.

The woman chiefly known as an author of “spirituality” books, announced Friday that she is forming a presidential exploratory committee and will head to Iowa where presidential hopefuls flock to test the waters.

“We had a miracle in this country in 1776, and we need another one,” Williamson said in a recent video. “It’s going to be a co-creative effort, an effort of love and a gift of love, to our country and hopefully to our world.” America needs to get “back to an ethical center that is the true exceptionalism of the American ideal,” she added.

Williamson, 66, is little known outside some circles in Hollywood, but she has dabbled in politics at least once before when she raised $2 million in 2014 to run as an independent against Democrat Rep. Henry Waxman in California.

Several celebrities endorsed Williamson’s 2014 run for Congress including actress Eva Longoria, Nicole Richie, Jane Lynch, Marcia Cross, and Alanis Morrissette. She also saw support from former Michigan Governor Jennifer Granholm and former Ohio Rep. Dennis Kucinich. She lost in a landslide.

While none of her past supporters have publicly admitted knowledge of her 2020 aspirations, some guessed that Williamson was working on the idea. The big clue was a job listing that appeared in Hollywood seeking a social media director for a presidential campaign that would be “part campaign, part startup, part spiritual movement,” for a female candidate who is a “non-politician, high-profile writer and spiritual personality.”

Williamson liberally mixed her chatter about spirituality in with her political commentary in 2014.

For instance, in one interview she criticized capitalism as forgetting that “When you see your fiduciary responsibility, which is the corporate matrix here, as the idea that you’re making more money is more important than the righteous balance of energy.”

She also claimed to be “left-wing” saying, “When it comes to policy, I’m definitely a left-wing Democrat. There’s no doubt about it, on policy.”

Still, after she lost, Williamson said that she learned to listen to herself, not her advisers, in politics.

“I kept waiting for people to tell me what to do and tried to hire people who would tell me what to do,” Williamson told Oprah. “It taught me what I should have already known: to only listen to myself.”

Williamson joins an avalanche of Democrats looking to a run for the White House including former Vice President Joe Biden, and Senators Kamala Harris, Cory “Spartacus” Booker, and Elizabeth Warren. Others include Maryland Congressman John Delaney, Billionaire and Second Amendment opponent Michael Bloomberg, porn star lawyer Michael Avenatti, small-time West Virginia politician Richard Ojeda, and global warming guru and billionaire Tom Steyer, among up to a dozen more.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 103

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 92

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 157

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Pete Crow-Armstrong Unveils Signature Baseball Gloves

Updated Category News Views 83

The Windy City Meets the Diamond Alright, bear with me here. Monday morning vibes, right? But here's something that'll turn your breakfast around if you're into baseball—or just the latest scoop on players making waves in gear. Pete Crow-Armstrong, the Chicago Cubs center fielder who's been lighting up the field, has his name on some fresh gear. We're talking signature...

Continue Reading
PAC Criticizes JD Vance's Billionaire Connections

Updated Category News Views 107

Unveiling Vance's High-Powered Backers Brace yourself for a fresh round of political sparring, folks. The Patriots for American Principles PAC has decided that JD Vance's relationships with the billionaire elite need a little more sunshine. And they're not shy about it—Vance's billionaires will be paraded around the streets of Washington D.C. on a mobile billboard,...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
Precision Biologics Unveils Promising Data on PB-223

Updated Category News Views 95

Precision's Big Reveal at SITC 2026 When it comes to the shifting tides of oncology advancements, Precision Biologics is making some serious waves. They're not leaning back; they're diving right in with their latest showcase at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2026. CEO Dr. Philip M. Arlen announced compelling preclinical data for their...

Continue Reading
Everest Group Faces Class Action: Key Investor Moves

Updated Category News Views 117

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Continue Reading
OncoC4's Cesalatamig: Promising Results in NSCLC Trials

Updated Category News Views 85

Hope in Persistence: Cesalatamig in the Spotlight Swinging through the medical landscape like a seasoned fighter, OncoC4's recent revelations at the SITC 2026 give investors and doctors a reason to pay close attention. We're sizing up their investigational drug, cesalatamig, which flaunts a solid objective response rate of 33% among non-small cell lung cancer (NSCLC)...

Continue Reading

Top 5 Most Recently Viewed Articles

Shipley Donuts Expands to Vienna, Delight in Every Bite

Updated Category News Views 73

Shipley Donuts: A Sweet Texas Tradition Lands in Virginia The donut world just got a little tastier in Northern Virginia as Shipley Donuts, that iconic Texan sweetheart, opened shop in Vienna. We're talking handmade donuts, done the old-school way, with a taste that makes you wanna grab a dozen before work. They’ve been crafting this magic for nearly a century, starting...

Continue Reading
Volato's Strategic Expansion with Gulfstream G280 Deliveries

Updated Category News Views 224

Volato's Exciting Addition to Its Fleet Volato Group, Inc. (the "Company" or "Volato") (NYSE American: SOAR), a frontrunner in private aviation, is thrilled to announce a significant milestone: the delivery of its second Gulfstream G280 is set for January 2025. This delivery is part of a strategic order of four aircraft and underscores the company’s proactive approach...

Continue Reading
Velico's Partnership with South Texas Blood Center Revolutionizes Plasma Access

Updated Category News Views 355

Transforming Plasma Access with Innovative Technology In a historic move, the South Texas Blood and Tissue Center (STBT) has become the first civilian blood center in the U.S. to adopt Velico, Inc.'s revolutionary FrontlineODP™ system. This groundbreaking partnership aims to enhance emergency medical practices by providing on-demand spray-dried plasma, making...

Continue Reading
The Incredible Growth of Teradyne: A Decade of Investment

Updated Category News Views 119

Investing in Teradyne: A Decade of Incredible Returns When it comes to long-term investments, certain stocks have consistently proven their worth. Teradyne (NASDAQ: TER) is one such company that has outperformed market expectations over the past decade. With an impressive annualized performance exceeding 11.62%, Teradyne has become a staple in many investors' portfolios....

Continue Reading
Grid Battery Metals Expands Copper Portfolio for Future Growth

Updated Category News Views 126

Grid Battery Metals' Exciting New Copper Acquisition Grid Battery Metals Inc. has made a significant move by acquiring a new copper project, broadening its portfolio in the battery metals sector. Tim Fernback, the President and CEO, articulated the strategic importance of this acquisition and its implications for future exploration activities. Strategic Location of the...

Continue Reading